Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin receptor 1E (5-HT1E) is a Gi/o-coupled G protein-coupled receptor primarily expressed in the frontal cortex, hippocampus, olfactory bulb, caudate putamen, and amygdala in humans. Activation inhibits adenylate cyclase, decreasing cAMP levels. Its precise physiological function is still unclear due to the lack of selective pharmacological tools and animal models (absent in rodents). Hypothesized roles include memory regulation, neuroprotection, immune modulation, and involvement in cell survival pathways, including potential links to cancer progression. There are currently no approved drugs targeting specifically the human serotonin receptor 1E.
Gi/o protein-coupled receptor; inhibits adenylate cyclase activity, leading to decreased cAMP levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin receptor 1E (5-HT1E).